Protalix BioTherapeutics, Inc. (PLX)

ASE – Real Time Price. Currency in USD

2.68

+0.25 (10.25%)

Market open: Aug 12, 2026, 1:16 PM EDT

2.40

-0.03 (-1.23%)

Previous after-hours: Aug 11, 2026, 7:44 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

53M

65M

48M

Cost of goods sold

-28M

-24M

-23M

-20M

Gross Profit

25M

29M

43M

28M

Operating expenses (excl. COGS)

-31M

-25M

-32M

-41M

Operating Income

-6M

10M

-13M

Non-operating income, total

-108K

237K

-2M

-1M

Pretax income

-6M

-14M

Equity in earnings

Taxes

-996K

-1M

-254K

-530K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-7M

-15M

Discontinued operations

Net income

-7M

-15M

Dilution adjustment

39K

-1M

Preferred dividends

Protalix BioTherapeutics, Inc. (PLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Protalix BioTherapeutics, Inc. (PLX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Protalix BioTherapeutics, Inc. (PLX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Protalix BioTherapeutics, Inc. (PLX)

Income Statement (Annual)

Income Statement (Annual)